Multiple Myeloma in Relapse Active Not Recruiting Phase 2 Trials for Pomalidomide (DB08910)

IndicationStatusPhase
DBCOND0036092 (Multiple Myeloma in Relapse)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs